Cargando…
17-Aminogeldanamycin Inhibits Constitutive Nuclear Factor-Kappa B (NF-κB) Activity in Patient-Derived Melanoma Cell Lines
Melanoma remains incurable skin cancer, and targeting heat shock protein 90 (HSP90) is a promising therapeutic approach. In this study, we investigate the effect of 17-aminogeldanamycin, a potent HSP90 inhibitor, on nuclear factor-kappa B (NF-κB) activity in BRAF(V600E) and NRAS(Q61R) patient-derive...
Autores principales: | Hartman, Mariusz L., Rogut, Magdalena, Mielczarek-Lewandowska, Aleksandra, Wozniak, Michal, Czyz, Malgorzata |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7312877/ https://www.ncbi.nlm.nih.gov/pubmed/32466509 http://dx.doi.org/10.3390/ijms21113749 |
Ejemplares similares
-
17-Aminogeldanamycin selectively diminishes IRE1α-XBP1s pathway activity and cooperatively induces apoptosis with MEK1/2 and BRAF(V600E) inhibitors in melanoma cells of different genetic subtypes
por: Mielczarek-Lewandowska, Aleksandra, et al.
Publicado: (2019) -
Inhibitors of HSP90 in melanoma
por: Mielczarek-Lewandowska, Aleksandra, et al.
Publicado: (2019) -
What Is Nuclear Factor Kappa B (NF-κB) Doing in and to the Mitochondrion?
por: Albensi, Benedict C.
Publicado: (2019) -
Prevalence of bortezomib-resistant constitutive NF-kappaB activity in mantle cell lymphoma
por: Yang, David T, et al.
Publicado: (2008) -
Targeting constitutive NF-κB specifically in tumor cells
por: Jeong, Ji-Hak, et al.
Publicado: (2017)